益丰药房(603939.SH)：第三季度净利润同比上升10.14%

Core Viewpoint - Yifeng Pharmacy (603939.SH) reported a year-on-year increase in revenue and net profit for Q3 2025, indicating positive financial performance and growth potential in the pharmaceutical retail sector [1] Financial Performance - The company's operating revenue for Q3 2025 reached 5.564 billion yuan, representing a year-on-year increase of 1.97% [1] - The net profit attributable to shareholders of the listed company was 345 million yuan, showing a year-on-year increase of 10.14% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 331 million yuan, reflecting a year-on-year increase of 8.08% [1]